Thierry Sulpice
Founder, Chairman, CEO and CSO @Physiogenex
Signup · Get unlimited contacts
WORK HISTORY
Founder, Chairman, CEO and CSO @Physiogenex
Physiogenex is a leading preclinical CRO specializing in metabolic disorders, diabetes, insulin resistance, obesity, fatty liver (NASH / NAFLD), dyslipidemia, atherosclerosis and cardiovascular complications.The company provides biopharmaceutical and agrofood industries with classical and proprietary diet-induced in vivo models, innovative in-house techniques (RCT) and gold standard methods (glucose clamps with radiolabelled tracers, …). The compnay also offers in vivo preclinical imaging services.
EDUCATION
University Joseph Fourier
Doctor of Philosophy (PhD), Physiopathology and Pharmacology
SKILLS
ABOUT THIERRY SULPICE
After 8 years as a leader in cardiometabolic research programs at Sanofi Aventis I started Physiogenex in 2004, a preclinical research organization (CRO) dedicated to the metabolic syndrome. I’m also founder of Betagenex (preclinical CRO specializing in beta-cell function) and Cardiomedex (a preclinical and clinical CRO dedicated to cardiovascular disorders with a specialization in the autonomic nervous system). Now I’m leading the Cardiometabolic Hub that includes all three companies through this consortium of highly specialized CRO offering complete array of services to accelerate preclinical research for biopharmaceutical and nutraceutical industries.My goal is to develop highly specialized, flexible and innovative research companies to provide clients’ with optimal and reliable solutions for successful strategic decision-making.I am also a scientific consultant for drug development plans, preclinical and post-marketing studies as well as drug repositioning in the field of metabolic and cardiovascular disorders.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.